Abrosimov Alexander, Saenko Vladimir, Meirmanov Serik, Nakashima Masahiro, Rogounovitch Tatiana, Shkurko Olesya, Lushnikov Eugeny, Mitsutake Norisato, Namba Hiroyuki, Yamashita Shunichi
Department of International Health and Radiation Research, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
Endocr Pathol. 2007 Summer;18(2):68-75. doi: 10.1007/s12022-007-0012-x.
This study addressed the immunohistochemical expression of MUC1 in papillary thyroid carcinoma (PTC) of different histotypes, sizes, and morphological features of aggressiveness, and its correlation with the overexpression of cyclin D1, a target molecule of the Wnt pathway. MUC1 expression was examined in a total of 209 PTCs. Cytoplasmic MUC1 expression was elevated in the tall, columnar cell and oncocytic variants (100%), Warthin-like (78%), and conventional PTCs (61%), and in papillary microcarcinoma (PMC) with the conventional growth pattern (52%). On the contrary, it was low in the follicular variant (27%) of PTC and PMCs with follicular architecture (13%). Cytoplasmic MUC1 accumulation did not associate with any clinicopathological features except peritumoral lymphoid infiltration in PTCs and in PMCs with the conventional growth pattern. MUC1 staining correlated with cyclin D1 overexpression in conventional PTCs and PMCs and PMCs with follicular architecture. The results demonstrate that MUC1 expression varies broadly in different histological variants of PTC, being the lowest in tumors with follicular structure. In general, it does not prove to be a prognosticator of PTC aggressiveness. A high correlation between MUC1 and cyclin D1 implies MUC1 involvement in the Wnt cascade functioning in a large subset of human PTCs and PMCs.
本研究探讨了MUC1在不同组织学类型、大小及侵袭性形态特征的甲状腺乳头状癌(PTC)中的免疫组化表达,及其与细胞周期蛋白D1(Wnt通路的靶分子)过表达的相关性。共检测了209例PTC中的MUC1表达。在高柱状细胞型、嗜酸性细胞型变体(100%)、Warthin样型(78%)和经典型PTC(61%)以及具有经典生长模式的甲状腺微小癌(PMC)中,细胞质MUC1表达升高。相反,在PTC的滤泡型变体(27%)和具有滤泡结构的PMC(13%)中,其表达较低。除了PTC和具有经典生长模式的PMC中的瘤周淋巴细胞浸润外,细胞质MUC1积累与任何临床病理特征均无关联。在经典型PTC、PMC以及具有滤泡结构的PMC中,MUC1染色与细胞周期蛋白D1过表达相关。结果表明,MUC1表达在PTC的不同组织学变体中差异很大,在具有滤泡结构的肿瘤中最低。总体而言,它并非PTC侵袭性的预后指标。MUC1与细胞周期蛋白D1之间的高度相关性意味着MUC1参与了人类大部分PTC和PMC中Wnt级联反应的功能。